Home›Search›Healthbook TIMES Oncology Hematology

Healthbook TIMES Oncology Hematology

The HealthBook Company Ltd · Switzerland · Est. 2019

ISSN2673-2106

SJR Q4✓ Scopus / SJR✓ DOAJ✓ Open Access

Journal Impact Factor

Not on record at PubScope. The Journal Impact Factor is published by Clarivate for Web of Science (JCR)–indexed journals. If this journal has one, it appears on the journal’s page ↗

📊 Standing in its field

Where this journal ranks among others in the same subject area.

SJR · Scopus

Bottom 25%

Clarivate’s JCR quartile is a separate ranking and may differ

SJR Scorei

0.157

H-Indexi

SNIPi

0.07

Total Worksi

218

Total Citationsi

2yr Mean Citednessi

0.28

Open Impact Factor alternative

Aims & Scope

healthbook TIMES Oncology Hematology publishes research articles, reviews, case reports, commentaries, and editorials in the fields of oncology and hematology. The journal focuses on practical experience, current evidence, treatment recommendations, and emerging paradigms in cancer and blood disorder treatment.

General Information

Country / RegionSwitzerland

Primary LanguageEnglish

1st Year Published2019

Annual Volume~ 36 articles / year

StatusActive (last: 2026)

Total Publications218

OA Since2018

Visit Journal Website

Submission Info

Peer ReviewSingle-blind

OA LicenseCC BY-NC-SA

OA Rate—

Ethics & Quality

COPE Member✗ No

OASPA Member✗ No

Not on Predatory Lists✓ Yes

Plagiarism Detection✓ Yes

Think.Check.Submit Compliance

thinkchecksubmit.org

9/11 · 82%

✅

Do you know the journal / publisher?

The HealthBook Company Ltd

✅

Does the journal have a website?

✓ Linked

✅

Is the ISSN verified?

2673-2106

✅

Indexed in a trusted database?

Scopus, DOAJ

✅

Peer review process documented?

Single-blind

❌

Follows ethical publishing standards (COPE)?

N/A

✅

Not on predatory/blacklists?

✓ Clean

❌

Long-term digital preservation?

N/A

✅

Plagiarism detection in place?

Yes

✅

Listed in DOAJ (verified OA)?

DOAJ verified

✅

Primary language documented?

English

A twelfth criterion — whether APC fees are clearly disclosed — is not scored here; it is left out of the total rather than counted as a failure. Publication charges appear in the metrics card above.

Based on the Think.Check.Submit framework by DOAJ, COPE & OASPA. All data from verified open sources.

Publication & Citation Trend

Articles published

Citations received

2019

2020

2021

2022

2023

2024

2025

2026

Source: OpenAlex · Each year’s green bar = citations earned by that year’s papers, counted to date — so recent years look lower simply because their papers haven’t had time to be cited yet.

SJR Quartile by Discipline

Scimago ranks this journal separately in each subject category — its quartile can differ by discipline.

HematologyQ4

OncologyQ4

Subject Classification

Scopus Categories

HematologyOncology

Research Topics (OpenAlex)

Economic and Financial Impacts of CancerLung Cancer Treatments and MutationsCAR-T cell therapy researchLymphoma Diagnosis and TreatmentHER2/EGFR in Cancer ResearchCancer Treatment and PharmacologyMultiple and Secondary Primary CancersOvarian cancer diagnosis and treatmentAcute Myeloid Leukemia ResearchProstate Cancer Treatment and Research

Frequently asked questions about Healthbook TIMES Oncology Hematology

Is Healthbook TIMES Oncology Hematology a predatory journal?

PubScope has no integrity flags on record for Healthbook TIMES Oncology Hematology: it is indexed in Scopus, DOAJ, and is not on DOAJ's withdrawn list. Indexing is a transparency signal, not a guarantee — always confirm fit and policies before submitting.

What is the impact factor of Healthbook TIMES Oncology Hematology?

Healthbook TIMES Oncology Hematology is not in the Web of Science Core Collection, so it has no official Clarivate Journal Impact Factor. Its SCImago SJR score is 0.157.

Is Healthbook TIMES Oncology Hematology indexed in Scopus and Web of Science?

Healthbook TIMES Oncology Hematology is indexed in Scopus, DOAJ.